| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |